Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications.
about
Myeloid-derived suppressor cells as regulators of the immune systemOxidative stress and apoptosis induced by hydroxyapatite nanoparticles in C6 cells.High levels of reactive oxygen species in gold nanoparticle-targeted cancer cells following femtosecond pulse irradiationMn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cellsSelective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl) propiolate.Catalytic organometallic anticancer complexesAlantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway.ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells.Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants.Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cellsMyeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.The evolving use of arsenic in pharmacotherapy of malignant disease.Myeloid-derived suppressor cells in cancer: recent progress and prospects.Cytotoxicity of arctigenin and matairesinol against the T-cell lymphoma cell line CCRF-CEM.Catalytically active bovine serum amine oxidase bound to fluorescent and magnetically drivable nanoparticlesImmunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer.
P2860
Q28131637-98C567AE-9F19-4AE4-A3FA-EDC734FFCB72Q34115994-FE51634C-EA22-440A-BCBA-5FCF6B49C8ACQ34355624-F5937E9D-DCA5-4630-99F1-8FB716947820Q35496324-69BF1434-67D0-49BA-9357-F73912F12925Q35597124-2137D86E-99E3-4F1F-954C-13B2C261072FQ36724891-55DDA85C-8DCD-4564-B0B4-9C57B28EE955Q36823229-48C459C4-5E8D-4A66-86AC-D271511D6B2FQ36954512-259D0F04-F425-4411-8945-F480E4AC05D1Q37072265-1E6759F6-9FA6-42C9-8505-E298C23FABA7Q37291308-B2E0E9EE-D76B-4EC0-AB17-39707A739523Q37923379-3D359EEF-9411-48FC-9793-A8EB10FF25D1Q37982182-F3CA0EAF-58B7-4658-BAF0-542840C46868Q38028470-E21AD849-2C11-419A-888B-AA4B7C33D595Q38089629-45D8665C-08E4-47C6-8BF9-FCD5CF5C429DQ38116711-3E77ABF9-1602-4010-AC24-A48364604148Q38881098-FC040820-E3F2-4B5A-B37B-D6A85F3AF36EQ39614342-3E754495-861A-49D5-9501-BA7D5C958F4FQ54918600-A4DCC3AE-4D1D-4C04-A586-5F999EC21050
P2860
Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@ast
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@en
type
label
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@ast
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@en
prefLabel
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@ast
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@en
P2860
P1433
P1476
Non-irradiation-derived reacti ...... cer: therapeutic implications.
@en
P2093
Agostinelli E
P2860
P2888
P304
P356
10.1007/S00726-005-0271-8
P577
2006-05-10T00:00:00Z